Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Conformis, Inc. (CFMS)

3.4101   -0.02 (-0.58%) 12-06 09:33
Open: 3.33 Pre. Close: 3.43
High: 3.4101 Low: 3.41
Volume: 1,643 Market Cap: 26(M)

Technical analysis

as of: 2022-12-06 9:17:31 AM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 4.49     One year: 5.25
Support: Support1: 2.21    Support2: 1.2
Resistance: Resistance1: 3.84    Resistance2: 4.49
Pivot: 2.3
Moving Average: MA(5): 3.17     MA(20): 2.22
MA(100): 5.03     MA(250): 10.3
MACD: MACD(12,26): 0     Signal(9): -0.3
Stochastic oscillator: %K(14,3): 87.6     %D(3): 91.3
RSI: RSI(14): 59.5
52-week: High: 21.29  Low: 0.27
Average Vol(K): 3-Month: 113 (K)  10-Days: 259 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ CFMS ] has closed below upper band by 11.7%. Bollinger Bands are 2.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.54 - 3.56 3.56 - 3.57
Low: 2.99 - 3 3 - 3.01
Close: 3.4 - 3.43 3.43 - 3.45

Company Description

Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, a custom-made partial knee replacement option for either unicompartmental or bicompartmental osteoarthritis of the knee; iTotal CR, a cruciate retaining total knee replacement product; iTotal PS, a posterior stabilized knee replacement product, as well as provides iTotal Identity and Identity Imprint knee replacement products. It also provides Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation. The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, the United Arab Emirates, the Sultanate of Oman, Italy, Poland, and other markets. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts.

Headline News

Fri, 02 Dec 2022
CFMS Choir Performs at Kiwanis of Camden - Camden News

Thu, 01 Dec 2022
Ra Medical, Vaxxinity top healthcare gainers; Aziyo, SQZ Biotechnologies among losers - Seeking Alpha

Thu, 01 Dec 2022
Conformis regains Nasdaq compliance - Seeking Alpha

Wed, 30 Nov 2022
Conformis regains compliance with Nasdaq listing requirement - Mass Device

Tue, 29 Nov 2022
Conformis announces first implants of Actera hip system - Mass Device

Fri, 25 Nov 2022
ConforMIS Inc (CFMS) Stock Gains 35.44% This Week: Is It a Good Pick? - InvestorsObserver

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 8 (M)
Shares Float 6 (M)
% Held by Insiders 3.7 (%)
% Held by Institutions 44.5 (%)
Shares Short 11 (K)
Shares Short P.Month 34 (K)

Stock Financials

EPS -0.04
EPS Est Next Qtl -0.32
EPS Est This Year -1.3
EPS Est Next Year -1.08
Book Value (p.s.) 8.14
Profit Margin (%) -104.5
Operating Margin (%) -88.1
Return on Assets (ttm) -25.3
Return on Equity (ttm) -71.4
Qtrly Rev. Growth -3.3
Gross Profit (p.s.) 8.73
Sales Per Share 7.98
EBITDA (p.s.) -6.48
Qtrly Earnings Growth 0
Operating Cash Flow -33 (M)
Levered Free Cash Flow -16 (M)

Stock Valuations

PE Ratio -87.95
PEG Ratio 0
Price to Book value 0.42
Price to Sales 0.42
Price to Cash Flow -0.79

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.